Similar articles

• Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease.

  Christopher-Stine L, Wigley F. Christopher-Stine L, et al. J Rheumatol. 2003 Dec;30(12):2725-7. J Rheumatol. 2003. PMID: 14719225 No abstract available.
• Autoimmune Pitfalls of Anti-Tumor Necrosis Factor-Alpha Therapy.

  Roginić S, Jelić A, Stipić-Marković A, Marinko A, Artuković IN, Dušanka MK. Roginić S, et al. Isr Med Assoc J. 2015 Feb;17(2):117-9. Isr Med Assoc J. 2015. PMID: 26223091 No abstract available.
• Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.

  Carlson E, Rothfield N. Carlson E, et al. Arthritis Rheum. 2003 Apr;48(4):1165-6; author reply 1166. doi: 10.1002/art.11033. Arthritis Rheum. 2003. PMID: 12687569 No abstract available.
• TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.

  Williams VL, Cohen PR. Williams VL, et al. Int J Dermatol. 2011 May;50(5):619-25. doi: 10.1111/j.1365-4632.2011.04871.x. Int J Dermatol. 2011. PMID: 21506984 Review.
• Drug-induced lupus due to anti-tumor necrosis factor alpha agents.

  Costa MF, Said NR, Zimmermann B. Costa MF, et al. Semin Arthritis Rheum. 2008 Jun;37(6):381-7. doi: 10.1016/j.semarthrit.2007.08.003. Epub 2007 Oct 30. Semin Arthritis Rheum. 2008. PMID: 17977585 Review.